Martoma Prosecutors Could Get Doctor's Files Soon

Jun 13 2013 | 9:50am ET

Prosecutors are nearing a deal that would give them access to the computer files of the former medical professor who allegedly passed tips about drug trials to a former SAC Capital Advisors portfolio manager.

The University of Michigan, whose medical school employed Sidney Gilman for 35 years before his resignation in disgrace in November, is finalizing an agreement with federal prosecutors in New York, the Financial Times reports. A deal is expected by Monday, a day before the judge overseeing Mathew Martoma's trial was to hold a hearing on the matter.

Michigan said it is wary of producing confidential information about drug trials and patients, and has refused to disclose the encryption key to decode the files on Gilman's computer. Prosecutors have argued that his files could be critical to the case against Martoma.

Gilman is working with prosecutors and has admitted that he passed tips about Alzheimer's disease drug trials to Martoma from 2006 through 2008, allowing Martoma to make trades in the two drug companies leading the tests. Martoma allegedly earned or saved SAC a total of $276 million on the trades.


In Depth

Q&A: Schroders’ Forest Discusses Multi-Asset Investments On Eve Of U.S. Launch

Jul 17 2014 | 8:05am ET

Global investment manager Schroders has $446 billion in assets under management, $...

Lifestyle

Einhorns Busts At WSOP, Finishes In 173rd

Jul 15 2014 | 10:48am ET

Greenlight Capital founder David Einhorn’s World Series of Poker won’t end at...

Guest Contributor

Common Risk Parity Misperceptions

Jul 16 2014 | 11:02am ET

Over the past few years, risk parity has become a component of most investors’...

 

Sponsored Content

    Northern Trust Helps Hedge Funds Navigate Derivatives Regulations

    Jul 8 2014 | 10:48am ET

    The surge in derivatives regulation is among the most complex challenges facing the financial services industry today. Northern Trust’s Joshua Satten recently spoke with FINalternatives to share insights into the challenges presented by new regulation and explore how the industry is responding. Read more…

Publisher's Note